Giscombe R - Search Results

1

Serotonin and its 5-HT1 receptor in human mastocytosis.

Ritter M, El-Nour H, Hedblad MA, Butterfield JH, Beck O, Stephanson N, Holst M, Giscombe R, Azmitia EC, Nordlind K. Ritter M, et al. Among authors: giscombe r. Immunopharmacol Immunotoxicol. 2012 Aug;34(4):679-85. doi: 10.3109/08923973.2011.651222. Epub 2012 Feb 1. Immunopharmacol Immunotoxicol. 2012. PMID: 22268664 Clinical Trial.

2

Expression of CTLA-4 by human monocytes.

Wang XB, Giscombe R, Yan Z, Heiden T, Xu D, Lefvert AK. Wang XB, et al. Among authors: giscombe r. Scand J Immunol. 2002 Jan;55(1):53-60. doi: 10.1046/j.0300-9475.2001.01019.x. Scand J Immunol. 2002. PMID: 11841692 Free article.

3

B7-H3 and B7-H4 expression in non-small-cell lung cancer.

Sun Y, Wang Y, Zhao J, Gu M, Giscombe R, Lefvert AK, Wang X. Sun Y, et al. Among authors: giscombe r. Lung Cancer. 2006 Aug;53(2):143-51. doi: 10.1016/j.lungcan.2006.05.012. Epub 2006 Jun 19. Lung Cancer. 2006. PMID: 16782226

4

Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells.

Wang XB, Zheng CY, Giscombe R, Lefvert AK. Wang XB, et al. Among authors: giscombe r. Scand J Immunol. 2001 Nov;54(5):453-8. doi: 10.1046/j.1365-3083.2001.00985.x. Scand J Immunol. 2001. PMID: 11696196 Free article.

5

Human Soluble CD80 is generated by alternative splicing, and recombinant soluble CD80 binds to CD28 and CD152 influencing T-cell activation.

Kakoulidou M, Giscombe R, Zhao X, Lefvert AK, Wang X. Kakoulidou M, et al. Among authors: giscombe r. Scand J Immunol. 2007 Nov;66(5):529-37. doi: 10.1111/j.1365-3083.2007.02009.x. Scand J Immunol. 2007. PMID: 17953528 Free article.

6

Induction of T-cell activation by oxidized low density lipoprotein.

Frostegård J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J. Frostegård J, et al. Among authors: giscombe r. Arterioscler Thromb. 1992 Apr;12(4):461-7. doi: 10.1161/01.atv.12.4.461. Arterioscler Thromb. 1992. PMID: 1558837

7

Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence.

Wang XB, Kakoulidou M, Giscombe R, Qiu Q, Huang D, Pirskanen R, Lefvert AK. Wang XB, et al. Among authors: giscombe r. J Neuroimmunol. 2002 Sep;130(1-2):224-32. doi: 10.1016/s0165-5728(02)00228-x. J Neuroimmunol. 2002. PMID: 12225905

8

Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis.

Huang D, Giscombe R, Zhou Y, Pirskanen R, Lefvert AK. Huang D, et al. Among authors: giscombe r. J Neuroimmunol. 2000 Jun 1;105(1):69-77. doi: 10.1016/s0165-5728(00)00191-0. J Neuroimmunol. 2000. PMID: 10713366

9

Abnormal T cell receptor V gene usage in myasthenia gravis: prevalence and characterization of expanded T cell populations.

Xu BY, Giscombe R, Söderlund A, Troye-Blomberg M, Pirskanen R, Lefvert AK. Xu BY, et al. Among authors: giscombe r. Clin Exp Immunol. 1998 Sep;113(3):456-64. doi: 10.1046/j.1365-2249.1998.00675.x. Clin Exp Immunol. 1998. PMID: 9737677 Free PMC article.

10

Single-nucleotide polymorphisms in the B7H3 gene are not associated with human autoimmune myasthenia gravis.

Sakthivel P, Wang X, Gharizadeh B, Giscombe R, Pirskanen R, Nyren P, Lefvert AK. Sakthivel P, et al. Among authors: giscombe r. J Genet. 2006 Dec;85(3):217-20. doi: 10.1007/BF02935335. J Genet. 2006. PMID: 17406098 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters